NNZ-2566: Phase II start

Next half, NEU will begin a placebo-controlled, Australian and New Zealand Phase II trial in 150 patients to evaluate a 20 mg/kg bolus of NNZ-2566 followed by a 6 mg/kg/hour IV infusion of NNZ-2566 fo...